Cited by 2,149Multiple Sclerosis Research StudiesT-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis

The DOI matches its Crossref record; 362 of the 362 references it cites were found in a registry or an index.

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Sospedra, Mireia, Martin, Roland·2005·Annual Review of Immunology

DOI 10.1146/annurev.immunol.23.021704.115707

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) develops in young adults with a complex predisposing genetic trait and probably requires an inciting environmental insult such as a viral infection to trigger the disease. The activation of CD4+ autoreactive T cells and their differentiation into a Th1 phenotype are a crucial events in the initial steps, and these cells are probably also important players in the long-term evolution of the disease. Damage of the target tissue, the central nervous system, is, however, most likely mediated by other components of the immune system, such as antibodies, complement, CD8+ T cells, and factors produced by innate immune cells. Perturbations in immunomodulatory networks that include Th2 cells, regulatory CD4+ T cells, NK cells, and others may in part be responsible for the relapsing-remitting or chronic progressive nature of the disease. However, an important paradigmatic shift in the study of MS has occurred in the past decade. It is now clear that MS is not just a disease of the immune system, but that factors contributed by the central nervous system are equally important and must be considered in the future.

Integrity signals

Registry

Crossref · 10.1146/annurev.immunol.23.021704.115707

Cites

362 of 362 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. M. (2003) · Science · doi:10.1126/science.1078231 · Cited by 2,000
Use of a cDNA microarray to analyse gene expression patterns in human cancer
DeRisi, J. L., Penland, L., Brown, P. O., Bittner, M. L., Meltzer, P. S., Ray, M., Chen, Y.-W., Su, Y. A., & Trent, J. M. (1996) · Nature Genetics · doi:10.1038/ng1296-457 · Cited by 1,952
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali‐Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J. E., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,918
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher‐Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,858
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M. N., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,683
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
Johnson, K., Brooks, B., Cohen, J. A., Ford, C., Goldstein, J., Lisak, R., Myers, L., Panitch, H., Rose, J., Schiffer, R., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,667

Show all 362 references

Research works printed but not linked: 12

McFarland HF, 1999, Am. J. Neuroradiol., 20, 1777
10.1172/JCI200421357 · DOI
Charcot J, 1868, Gaz. Hopitaux, 41, 554
Remlinger J, 1905, Ann. Inst. Pasteur, 19, 625
Berger T, 1997, Lab. Invest., 76, 355
10.1097/00019052-200306000-00004 · DOI
Sharief MK, 1991, Brain, 114, 181
Bornstein MB, 1959, Trans. Am. Neurol. Assoc., 84, 165
10.1002/1531-8249(200006)47:6<694::AID-ANA2>3.0.CO;2-W · DOI
Linington C, 1988, Am. J. Pathol., 130, 443
Benczur M, 1980, Clin. Exp. Immunol., 39, 657
10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-# · DOI

Sorted by citations

Items 201–300 of 1,006

Smoking is a risk factor for early conversion to clinically definite multiple sclerosis
Pauli, F. D., Reindl, M., Ehling, R., Schautzer, F., Gneiss, C., Lutterotti, A., O’Reilly, É., Munger, K. L., Deisenhammer, F., Ascherio, A., et al. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508093679 · Cited by 141
Freedom from disease activity in multiple sclerosis
Havrdová, E., Galetta, S. L., Stefoski, D., & Comı, G. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dbb51c · Cited by 140
Antibody therapies in CNS diseases
Freskgård, P., & Urich, E. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.014 · Cited by 144
Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance
Salehipour, Z., Haghmorad, D., Sankian, M., Rastin, M., Nosratabadi, R., Dallal, M. M. S., Tabasi, N. S., Khazaee, M., Nasiraie, L. R., & Mahmoudi, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.117 · Cited by 143
Cutting Edge: TLR3 Stimulation Suppresses Experimental Autoimmune Encephalomyelitis by Inducing Endogenous IFN-β
Touil, T., Fitzgerald, D. C., Zhang, G., Rostami, A. M., & Gran, B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7505 · Cited by 139
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis
Elliott, C., Lindner, M., Arthur, A. T., Brennan, K., Jarius, S., Hussey, J., Chan, A., Salmen, A., Olsson, T. P., Willison, H. J., et al. (2012) · Brain · doi:10.1093/brain/aws105 · Cited by 138
Inflammation in Neurological Disorders: The Thin Boundary Between Brain and Periphery
Cervellati, C., Trentini, A., Pecorelli, A., & Valacchi, G. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8076 · Cited by 140
Green tea EGCG, T cells, and T cell-mediated autoimmune diseases
Wu, D., Wang, J., Pae, M., & Meydani, S. N. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.001 · Cited by 138
Lipocalin-2 Protein Deficiency Ameliorates Experimental Autoimmune Encephalomyelitis
Nam, Y., Kim, J.-H., Seo, M., Kim, J., Jin, M., Jeon, S., Seo, J.-W., Lee, W., Bing, S. J., Jee, Y., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.542282 · Cited by 137
CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions
Krumbholz, M., Theil, D. J., Steinmeyer, F., Cepok, S., Hemmer, B., Hofbauer, M., Farina, C., Derfuss, T. J., Junker, A., Arzberger, T., et al. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.07.024 · Cited by 141
Epstein-Barr Virus in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis—Association and Causation
Lossius, A., Johansen, J. N., Torkildsen, Ø., Vartdal, F., & Holmøy, T. (2012) · Viruses · doi:10.3390/v4123701 · Cited by 137
Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease
Liu, X., Leung, S., Wang, C., Tan, Z., Wang, J., Guo, T. B., Fang, L., Zhao, Y., Wan, B., Qin, X., et al. (2010) · Nature Medicine · doi:10.1038/nm.2077 · Cited by 144
Retracted
Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients
Gingele, S., Jacobus, T. L., Konen, F. F., Hümmert, M. W., Sühs, K., Schwenkenbecher, P., Ahlbrecht, J., Möhn, N., Müschen, L. H., Bönig, L., et al. (2018) · Cells · doi:10.3390/cells8010012 · Cited by 141
Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis
Rosa, V. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26523 · Cited by 139
The Lactic Acid Bacterium Pediococcus acidilactici Suppresses Autoimmune Encephalomyelitis by Inducing IL-10-Producing Regulatory T Cells
Takata, K., Kinoshita, M., Okuno, T., Moriya, M., Kohda, T., Honorat, J. A., Sugimoto, T., Kumanogoh, A., Kayama, H., Takeda, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027644 · Cited by 140
Opposing Functions of Microglial and Macrophagic TNFR2 in the Pathogenesis of Experimental Autoimmune Encephalomyelitis
Gao, H., Danzi, M. C., Choi, C. S., Taherian, M., Hansen, C. D., Ellman, D. G., Madsen, P. M., Bixby, J. L., Lemmon, V., Lambertsen, K. L., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.11.083 · Cited by 140
Multiple sclerosis: molecular pathogenesis and therapeutic intervention
Boutitah-Benyaich, I., Eixarch, H., Villacieros‐Álvarez, J., Hervera, A., Cobo‐Calvo, Á., Montalbán, X., & Espejo, C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02415-4 · Cited by 149
The role of chemokines and chemokine receptors in multiple sclerosis
Cui, L.-Y., Chu, S.-F., & Chen, N.-H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106314 · Cited by 135
Brain-Reactive Antibodies and Disease
Diamond, B., Honig, G., Mader, S., Brimberg, L., & Volpe, B. T. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075041 · Cited by 138
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
Han, S., Thatte, J., Buzard, D. J., & Jones, R. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4005626 · Cited by 136
Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune diseases and immunosenescence
Choi, I. Y., Lee, C., & Longo, V. D. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.042 · Cited by 133
Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy
Pender, M. P., & Burrows, S. R. (2014) · Clinical & Translational Immunology · doi:10.1038/cti.2014.25 · Cited by 133
Role of Pathogens in Multiple Sclerosis
Libbey, J. E., Cusick, M. F., & Fujinami, R. S. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.823422 · Cited by 136
Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis
von Essen, M. R., Ammitzbøll, C., Hansen, R. H., Petersen, E. R., McWilliam, O. H., Marquart, H. V., Damm, P., & Sellebjerg, F. T. (2018) · Brain · doi:10.1093/brain/awy301 · Cited by 132
Suppression of Microglial Inflammatory Activity by Myelin Phagocytosis: Role of p47-PHOX-Mediated Generation of Reactive Oxygen Species
Liu, Y., Hao, W., Letièmbre, M., Walter, S., Kulanga, M., Neumann, H., & Fassbender, K. C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2531-06.2006 · Cited by 139
Correlations between peripheral blood mononuclear cell production of BDNF, TNF‐alpha, IL‐6, IL‐10 and cognitive performances in multiple sclerosis patients
Patanella, A. K., Zinno, M., Quaranta, D., Nociti, V., Frisullo, G., Gainotti, G., Tonali, P., Batocchi, A. P., & Marra, C. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22276 · Cited by 131
Intercellular Adhesion Molecule-1 Expression Is Required on Multiple Cell Types for the Development of Experimental Autoimmune Encephalomyelitis
Bullard, D. C., Hu, X., Schoeb, T. R., Collins, R. G., Beaudet, A. L., & Barnum, S. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.851 · Cited by 130
Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation
Raveney, B. J. E., Oki, S., Hohjoh, H., Nakamura, M., Sato, W., Murata, M., & Yamamura, T. (2015) · Nature Communications · doi:10.1038/ncomms9437 · Cited by 134
Venous hemodynamics in neurological disorders: an analytical review with hydrodynamic analysis
Beggs, C. B. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-142 · Cited by 130
Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on 4 integrin
Ifergan, I., Kébir, H., Alvarez, J. I., Marceau, G., Bernard, M., Bourbonnière, L., Poirier, J., Duquette, P., Talbot, P. J., Arbour, N., et al. (2011) · Brain · doi:10.1093/brain/awr268 · Cited by 136
The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects
Sørensen, P. S., & Blinkenberg, M. (2015) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285615601933 · Cited by 129
Neuroinflammation and Endoplasmic Reticulum Stress Are Coregulated by Crocin To Prevent Demyelination and Neurodegeneration
Deslauriers, A. M., Afkhami-Goli, A., Paul, A. M., Bhat, R. K., Acharjee, S., Ellestad, K. K., Noorbakhsh, F., Michalak, M., & Power, C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004111 · Cited by 130
Cytokine profile in relapsing-remitting multiple sclerosis patients and the association between progression and activity of the disease
Kallaur, A. P., Oliveira, S. R., Simão, A. N. C., de Almeida, E. R. D., Morimoto, H. K., Lopes, J. M., Pereira, W. L. D. C. J., ANDRADE, R. M., Pelegrino, L. M., Borelli, S. D., et al. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1256 · Cited by 138
Cytokines and effector T cell subsets causing autoimmune CNS disease
Petermann, F., & Korn, T. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.064 · Cited by 134
Human endogenous retroviruses and multiple sclerosis: Innocent bystanders or disease determinants?
Antony, J. M., Deslauriers, A. M., Bhat, R. K., Ellestad, K. K., & Power, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.016 · Cited by 135
Peripheral Tolerance Induction Using Ethylenecarbodiimide-Fixed APCs Uses both Direct and Indirect Mechanisms of Antigen Presentation for Prevention of Experimental Autoimmune Encephalomyelitis
Turley, D. M., & Miller, S. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2212 · Cited by 126
Atacicept: targeting B cells in multiple sclerosis
Hartung, H., & Kieseier, B. C. (2010) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285610371146 · Cited by 129
Insight into the mechanism of laquinimod action
Brück, W., & Wegner, C. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.02.019 · Cited by 126
Acute Disseminated Encephalomyelitis: Clinical and Pathogenesis Features
Noorbakhsh, F., Johnson, R. T., Emery, D. J., & Power, C. (2008) · Neurologic Clinics · doi:10.1016/j.ncl.2008.03.009 · Cited by 126
Deimination of membrane-bound myelin basic protein in multiple sclerosis exposes an immunodominant epitope
Musse, A. A., Boggs, J. M., & Harauz, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509158103 · Cited by 126
Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis
Mehling, M., Johnson, T., Antel, J. P., Kappos, L., & Bar‐Or, A. (2011) · Neurology · doi:10.1212/wnl.0b013e31820db341 · Cited by 128
Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity
Breuer, J., Schwab, N., Schneider‐Hohendorf, T., Marziniak, M., Mohan, H., Bhatia, U., Groß, C. C., Clausen, B. E., Weishaupt, C., Luger, T. A., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24165 · Cited by 135
Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis
Martinꝉ, R., Sospedra, M., Rosito, M., & Engelhardt, B. (2016) · European Journal of Immunology · doi:10.1002/eji.201646485 · Cited by 133
Self-citation
Anti‐Inflammatory Effect of Quercetin on RAW 264.7 Mouse Macrophages Induced with Polyinosinic‐Polycytidylic Acid
Kim, Y., & Park, W. (2016) · Molecules · doi:10.3390/molecules21040450 · Cited by 125
The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytes
Rijkers, E. S. K., Ruiter, T. E.-D., Baridi, A., Veninga, H., Hoek, R. M., & Meyaard, L. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.07.013 · Cited by 124
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study
Pitteri, M., Romualdi, C., Magliozzi, R., Monaco, S., & Calabrese, M. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516665496 · Cited by 124
CNS: Not an immunoprivilaged site anymore but a virtual secondary lymphoid organ
Negi, N., & Das, B. K. (2018) · International Reviews of Immunology · doi:10.1080/08830185.2017.1357719 · Cited by 123
An overview on neuroprotective effects of isothiocyanates for the treatment of neurodegenerative diseases
Giacoppo, S., Galuppo, M., Montaut, S., Iori, R., Rollin, P., Bramanti, P., & Mazzon, E. (2015) · Fitoterapia · doi:10.1016/j.fitote.2015.08.001 · Cited by 126
Involvement of CD8+ T Cells in Multiple Sclerosis
Salou, M., Nicol, B., Garcia, A., & Laplaud, D. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00604 · Cited by 135
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype
Kozela, E., Juknat, A., Kaushansky, N., Rimmerman, N., Ben‐Nun, A., & Vogel, Z. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9493-1 · Cited by 124
Cerebrospinal Fluid B Cells Correlate with Early Brain Inflammation in Multiple Sclerosis
Kuenz, B., Lutterotti, A., Ehling, R., Gneiss, C., Hämmerle, M., Rainer, C., Deisenhammer, F., Schocke, M. F. H., Berger, T., & Reindl, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002559 · Cited by 123
Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells
Montes, M., Zhang, X., Berthelot, L., Laplaud, D. A., Brouard, S., Jin, J., Rogan, S. C., Armao, D. M., Jewells, V. L., Soulillou, J., et al. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.08.030 · Cited by 123
Regulation of Th1 and Th17 Cell Differentiation and Amelioration of Experimental Autoimmune Encephalomyelitis by Natural Product Compound Berberine
Qin, X., Guo, B.-S., Wan, B., Fang, L., Lü, L., Wu, L., Zang, Y. Q., & Zhang, J. Z. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903853 · Cited by 122
Agent-Based Modeling of the Immune System: NetLogo, a Promising Framework
Chıacchıo, F., Pennisi, M. A., Russo, G. L., Motta, S., & Pappalardo, F. (2014) · BioMed Research International · doi:10.1155/2014/907171 · Cited by 122
Human Epistatic Interaction Controls IL7R Splicing and Increases Multiple Sclerosis Risk
Galarza-Muñoz, G., Briggs, F. B. S., Evsyukova, I. Y., Schott, G., Kennedy, E. M., Nyanhete, T. E., Wang, L., Bergamaschi, L., Widen, S. G., Tomaras, G. D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.007 · Cited by 124
Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone
Gold, S. M., Chalifoux, S. L., Giesser, B. S., & Voskuhl, R. R. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-32 · Cited by 120
EAE: An immunologist's magic eye
Krishnamoorthy, G., & Wekerle, H. (2009) · European Journal of Immunology · doi:10.1002/eji.200939568 · Cited by 120
Accounting for eXentricities: Analysis of the X Chromosome in GWAS Reveals X-Linked Genes Implicated in Autoimmune Diseases
Chang, D., Gao, F., Slavney, A., Ma, L., Waldman, Y. Y., Sams, A. J., Billing-Ross, P., Madar, A., Spritz, R. A., & Keinan, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113684 · Cited by 120
TCR recognition of peptide/MHC class II complexes and superantigens
Sundberg, E. J., Deng, L., & Mariuzza, R. A. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.04.006 · Cited by 122
Relapsing–Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T Cells
Sasaki, K., Bean, A., Shah, S., Schutten, E., Huseby, P. G., Peters, B., Shen, Z. T., Vanguri, V. K., Liggitt, D., & Huseby, E. S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302911 · Cited by 118
Combined exercise training reduces IFN-γ and IL-17 levels in the plasma and the supernatant of peripheral blood mononuclear cells in women with multiple sclerosis
Golzari, Z., Shabkhiz, F., Soudi, S., Kordi, M. R., & Hashemi, S. M. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.08.008 · Cited by 117
Mesenchymal stem cells and adaptive immune responses
Cao, W., Cao, K., Cao, J., Wang, Y., & Shi, Y. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.06.003 · Cited by 119
Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases
Riedhammer, C., & Weissert, R. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00322 · Cited by 124
Correlates of cognitive dysfunction in multiple sclerosis
Heesen, C., Schulz, K., Fiehler, J., Mark, U., Otte, C., Jung, R., Poettgen, J., Krieger, T., & Gold, S. M. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.05.006 · Cited by 116
IL-7 Promotes T H 1 Development and Serum IL-7 Predicts Clinical Response to Interferon-β in Multiple Sclerosis
Lee, L., Axtell, R. C., Tu, G. H., Logronio, K. A., Dilley, J., Yu, J., Rickert, M., Han, B., Evering, W., Walker, M. G., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002400 · Cited by 118
The role of exosomes in CNS inflammation and their involvement in multiple sclerosis
Selmaj, I., Mycko, M. P., Raine, C. S., & Selmaj, K. W. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.02.002 · Cited by 114
Anti-CD20 therapy depletes activated myelin-specific CD8 + T cells in multiple sclerosis
Sabatino, J. J., Wilson, M. R., Calabresi, P. A., Hauser, S. L., Schneck, J. P., & Zamvil, S. S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1915309116 · Cited by 118
Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer
Brevi, A., Cogrossi, L. L., Grazia, G., Masciovecchio, D., Impellizzieri, D., Lacanfora, L., Grioni, M., & Bellone, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.565470 · Cited by 114
Reticulon proteins: emerging players in neurodegenerative diseases
Yan, R., Shi, Q., Hu, X., & Zhou, X. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5338-2 · Cited by 113
The role of stress-response systems for the pathogenesis and progression of MS
Gold, S. M., Mohr, D. C., Huitinga, I., Flachenecker, P., Sternberg, E. M., & Heesen, C. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.09.010 · Cited by 119
Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease
Toft‐Hansen, H., Füchtbauer, L. M., & Owens, T. (2010) · Glia · doi:10.1002/glia.21088 · Cited by 113
Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR15
Zdimerova, H., Murer, A., Engelmann, C., Raykova, A., Deng, Y., Gujer, C., Rühl, J., McHugh, D., Caduff, N., Naghavian, R., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.202048655 · Cited by 116
Self-citation
Immunomodulation mechanism of antidepressants: interactions between serotonin/norepinephrine balance and Th1/Th2 balance
Martino, M., Rocchi, G., Escelsior, A., & Fornaro, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604542 · Cited by 111
GDP- l -fucose synthase is a CD4 + T cell–specific autoantigen in DRB3*02:02 patients with multiple sclerosis
Planas, R., Santos, R. G., Ojer, P. T., Cruciani, C., Lutterotti, A., Faigle, W., Schaeren‐Wiemers, N., Espejo, C., Eixarch, H., Pinilla, C., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat4301 · Cited by 115
Self-citation
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease
Arron, H. E., Marsh, B. D., Khan, M. A., Jaeger, B., Kell, D., & Pretorius, E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1386607 · Cited by 127
Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease
Chastain, E. M. L., & Miller, S. D. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01076.x · Cited by 110
Cannabinoids and Multiple Sclerosis
Pertwee, R. G. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0005-2 · Cited by 112
Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2Receptor Agonists
Tabrizi, M. A., Baraldi, P. G., Borea, P. A., & Varani, K. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00411 · Cited by 111
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
Calabrese, M., Preziosa, P., Scalfari, A., Colato, E., Marastoni, D., Absinta, M., Battaglini, M., Stefano, N. D., Filippo, M. D., Hametner, S., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26913 · Cited by 115
Self-citation
A temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis
Mohr, D. C., & Pelletier, D. (2005) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2005.03.011 · Cited by 113
Blocking A2B Adenosine Receptor Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis via Inhibition of IL-6 Production and Th17 Differentiation
Wei, W., Du, C., Lv, J., Zhao, G., Li, Z., Wu, Z., Haskó, G., & Xie, X. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103721 · Cited by 110
Amelioration of Experimental Autoimmune Encephalomyelitis in C57BL/6 Mice by Photobiomodulation Induced by 670 nm Light
Muili, K. A., Gopalakrishnan, S., Meyer, S. L., Eells, J. T., & Lyons, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030655 · Cited by 109
Insulin resistance, inflammation, and cognition in Alzheimer's Disease: Lessons for multiple sclerosis
Watson, G. S., & Craft, S. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.08.017 · Cited by 111
Up-Regulation of Soluble Axl and Mer Receptor Tyrosine Kinases Negatively Correlates with Gas6 in Established Multiple Sclerosis Lesions
Weinger, J. G., Omari, K. M., Marsden, K. C., Raine, C. S., & Shafit‐Zagardo, B. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080807 · Cited by 110
Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?
Brown, M. A., & Hatfield, J. K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00147 · Cited by 109
Synergistic activity of interleukin-17 and tumor necrosis factor-α enhances oxidative stress-mediated oligodendrocyte apoptosis
Paintlia, M. K., Paintlia, A. S., Singh, A. K., & Singh, I. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07136.x · Cited by 111
Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response
Hernández‐Pedro, N., Espinosa-Ramírez, G., de la Cruz, V. P., Pineda, B., & Sotelo, J. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/413465 · Cited by 113
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes
Perriard, G., Mathias, A., Enz, L., Canales, M., Schluep, M., Gentner, M., Schaeren‐Wiemers, N., & Pasquier, R. D. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0335-3 · Cited by 114
Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitis
Trubiani, O., Giacoppo, S., Ballerini, P., Diomede, F., Piattelli, A., Bramanti, P., & Mazzon, E. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0253-4 · Cited by 107
Modulation by Melatonin of the Pathogenesis of Inflammatory Autoimmune Diseases
Lin, G., Huang, S., Chen, S., Wang, C., Chang, D., & Sytwu, H. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140611742 · Cited by 109
Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity
Stüve, O. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25805 · Cited by 107
MP4- and MOG:35–55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum☆
KUERTEN, S., KOSTOVABALES, D., FRENZEL, L., TIGNO, J., TARYLEHMANN, M., ANGELOV, D., & LEHMANN, P. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.06.016 · Cited by 107
Targeted immunomodulation of inflammatory monocytes across the blood-brain barrier by curcumin-loaded nanoparticles delays the progression of experimental autoimmune encephalomyelitis
Lu, L., Qi, S., Chen, Y., Luo, H., Huang, S., Yu, X. M., Luo, Q., & Zhang, Z. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119987 · Cited by 107
Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor α-chain are excluded from the analysis
Michel, L., Berthelot, L., Pettré, S., Wiertlewski, S., Lefrère, F., Braudeau, C., Brouard, S., Soulillou, J., & Laplaud, D. A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35365 · Cited by 110
Identification of a Novel Risk Locus for Multiple Sclerosis at 13q31.3 by a Pooled Genome-Wide Scan of 500,000 Single Nucleotide Polymorphisms
Comabella, M., Craig, D. W., Camiña-Tato, M., Morcillo, C., Lopez, C., Navarro, A., Rio, J., BiomarkerMS Study Group, Montalban, X., & Martin, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003490 · Cited by 105
Self-citation
Shedding light on biological sex differences and microbiota–gut–brain axis: a comprehensive review of its roles in neuropsychiatric disorders
Shobeiri, P., Kalantari, A., Teixeira, A. L., & Rezaei, N. (2022) · Biology of Sex Differences · doi:10.1186/s13293-022-00422-6 · Cited by 113
IL ‐17 and Glutamate Excitotoxicity in the Pathogenesis of Multiple Sclerosis
Kostić, M. S., Džopalić, T., Živanović, S. C., Živković, N., Cvetanović, A., Stojanović, I. R., Vojinović, S., Marjanović, G., Savic, V., & Čolić, M. J. (2014) · Scandinavian Journal of Immunology · doi:10.1111/sji.12147 · Cited by 109
CD8+ T cells in Autoimmunity
Tsai, S. J., Shameli, A., & Santamaría, P. (2008) · Inmunología · doi:10.1016/s0213-9626(08)70045-3 · Cited by 105
NKG2D-Mediated Cytotoxicity toward Oligodendrocytes Suggests a Mechanism for Tissue Injury in Multiple Sclerosis
Saikali, P., Antel, J. P., Newcombe, J., Chen, Z., Freedman, M. S., Blain, M., Cayrol, R., Prat, A., Hall, J. A., & Arbour, N. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4402-06.2007 · Cited by 104
Are Obesity-Related Insulin Resistance and Type 2 Diabetes Autoimmune Diseases?
Tsai, S. J., Clemente‐Casares, X., Revelo, X. S., Winer, S., & Winer, D. A. (2015) · Diabetes · doi:10.2337/db14-1488 · Cited by 104

Authors: Sospedra, M., & Martin, R.
Affiliations: National Institutes of Health (US)
Cellular Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400;
ORCID: Sospedra, Mireia
Venue: Annual Review of Immunology
Publisher: Annual Reviews
Published: 2005-04-01
Volume: 23
Issue: 1
Pages: 683-747
ISSN: 0732-0582 (ISSN-L)
1545-3278
DOI: 10.1146/annurev.immunol.23.021704.115707
OpenAlex: W2113291839
Cited by: 2,149
References: 362
Citations by year: 2026: 27 · 2025: 43 · 2024: 62 · 2023: 64 · 2022: 69 · 2021: 72 · 2020: 78 · 2019: 84 · 2018: 71 · 2017: 110 · 2016: 107 · 2015: 149 · 2014: 133 · 2013: 144 · 2012: 120
FWCI: 19.06
Type: journal article
Language: en
Open access: closed
Locations: Annual Review of Immunology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords: multiple sclerosis, autoimmunity, CD4+ T cells, Th1 cells, Th2 cells, regulatory T cells, natural killer cells, CD8+ T cells, complement system, autoantibodies, innate immunity, viral triggers, genetic susceptibility, relapsing-remitting disease, chronic progressive disease, central nervous system, neuroimmune interactions
MeSH terms: Autoantibodies, Autoantigens, Central Nervous System, HLA Antigens, Humans, Immunity, Innate, Immunogenetics, Infections, Multiple Sclerosis, Myelin Proteins, T-Lymphocyte Subsets, Cytokines, Models, Immunological, Molecular Mimicry, Chemokines, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks